Megan A Kirk1, Mohammad Amiri1, Meysam Pirbaglou1, Paul Ritvo1,2,3. 1. 1 School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada. 2. 2 Department of Psychology, York University, Toronto, Ontario, Canada. 3. 3 University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: To evaluate the effectiveness of wearable device interventions (eg, Fitbit) to improve physical activity (PA) outcomes (eg, steps/day, moderate to vigorous physical activity [MVPA]) in populations diagnosed with cardiometabolic chronic disease. DATA SOURCE: Based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses, an electronic search of 5 databases (Medline, PsychINFO, Scopus, Web of Science, and PubMed) was conducted. STUDY INCLUSION AND EXCLUSION CRITERIA: Randomized controlled trials (RCTs) published between January 2000 and May 2018 that used a wearable device for the full intervention in adults (18+) diagnosed with a cardiometabolic chronic disease were included. Excluded trials included studies that used devices at pre-post only, devices that administered medication, and interventions with no prospective control group comparison. DATA EXTRACTION: Thirty-five studies examining 4528 participants met the inclusion criteria. Study quality and RCT risk of bias were assessed using the Cochrane Collaboration Tool. DATA SYNTHESIS: Meta-analyses to compute PA (eg, steps/day) and selected physical dispersion and summary effects were conducted using the raw unstandardized pooled mean difference (MD). Sensitivity analyses were examined. RESULTS: Statistically significant increases in PA steps/day (MD = 2592 steps/day; 95% confidence interval [CI]: 1689-3496) and MVPA min/wk (MD = 36.31 min/wk; 95% CI: 18.33-54.29) were found for the intervention condition. CONCLUSION: Wearable devices positively impact physical health in clinical populations with cardiometabolic diseases. Future research using the most current technologies (eg, Fitbit) will serve to amplify these findings.
OBJECTIVE: To evaluate the effectiveness of wearable device interventions (eg, Fitbit) to improve physical activity (PA) outcomes (eg, steps/day, moderate to vigorous physical activity [MVPA]) in populations diagnosed with cardiometabolic chronic disease. DATA SOURCE: Based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses, an electronic search of 5 databases (Medline, PsychINFO, Scopus, Web of Science, and PubMed) was conducted. STUDY INCLUSION AND EXCLUSION CRITERIA: Randomized controlled trials (RCTs) published between January 2000 and May 2018 that used a wearable device for the full intervention in adults (18+) diagnosed with a cardiometabolic chronic disease were included. Excluded trials included studies that used devices at pre-post only, devices that administered medication, and interventions with no prospective control group comparison. DATA EXTRACTION: Thirty-five studies examining 4528 participants met the inclusion criteria. Study quality and RCT risk of bias were assessed using the Cochrane Collaboration Tool. DATA SYNTHESIS: Meta-analyses to compute PA (eg, steps/day) and selected physical dispersion and summary effects were conducted using the raw unstandardized pooled mean difference (MD). Sensitivity analyses were examined. RESULTS: Statistically significant increases in PA steps/day (MD = 2592 steps/day; 95% confidence interval [CI]: 1689-3496) and MVPA min/wk (MD = 36.31 min/wk; 95% CI: 18.33-54.29) were found for the intervention condition. CONCLUSION: Wearable devices positively impact physical health in clinical populations with cardiometabolic diseases. Future research using the most current technologies (eg, Fitbit) will serve to amplify these findings.
Authors: Deborah A Greenwood; Michelle L Litchman; Diana Isaacs; Julia E Blanchette; Jane K Dickinson; Allyson Hughes; Vanessa D Colicchio; Jiancheng Ye; Kirsten Yehl; Andrew Todd; Malinda M Peeples Journal: J Diabetes Sci Technol Date: 2021-08-11
Authors: Ana M Abrantes; Donnell Van Noppen; Genie Bailey; Lisa A Uebelacker; Matthew Buman; Michael D Stein Journal: Ment Health Phys Act Date: 2021-08-14
Authors: Sai Krupa Das; Akari J Miki; Caroline M Blanchard; Edward Sazonov; Cheryl H Gilhooly; Sujit Dey; Colton B Wolk; Chor San H Khoo; James O Hill; Robin P Shook Journal: Adv Nutr Date: 2022-02-01 Impact factor: 11.567
Authors: Jessica McNeil; Mina Fahim; Chelsea R Stone; Rachel O'Reilly; Kerry S Courneya; Christine M Friedenreich Journal: J Cancer Surviv Date: 2021-03-22 Impact factor: 4.442